Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

============================================================

Monday, October 31, 2016

AXIM Moving Ahead with Testing of Cannabinoid Products, Including Chewing Gum for MS Patients


                                                                  
  

Click here to receive MS news via e-mail

medical marijuana
AXIM Biotechnologies  announced it has secured financing from private sources to continue its testing of medical cannabinoid products as potential treatments for multiple indications, including pain and spasticity in people with multiple sclerosis (MS).
Specifically, AXIM  is testing pharmaceutical delivery systems and active ingredients for its medical marijuana line.
“This financing provides us with the opportunity to boldly continue our efforts in the extremely promising and intricate space of cannabinoid-based therapeutics,” George E. Anastassov, MD, DDS, MBA , AXIM Biotechnologies’ chief executive officer, said in a press release. “We’re pleased that our investors have the full trust that we do in our executive team and advisory board … leaders with proven track records in the multiple indications our company is developing products for.”
One of the company’s most promising therapeutics is MedChew Rx, a chewing gum containing cannabinoids, being developed to address pain and muscle spasticity in MS patients. The gum is designed to offer more consistent relief than existing cannabis-derived products meant to be smoked or eaten.

MS Views and News
Providing educational information, resources and services for those affected by MS

Relapses in MS Patients Using Gilenya May Be Result of Changes Within T-Cells, Study Reports


                                                                  
  

Click here to receive MS news via e-mail
shutterstock_296601893













Changes in the composition of certain immune system cells may be associated with relapses in multiple sclerosis (MS) patients being treated with Gilenya (fingolimod), according to a study published in the journal Scientific Reports.

In MS patients, immune cells called T-cells penetrate the brain and react against the myelin coating that protects and supports neurons. But before this autoimmune response occurs, T-cells undergo certain migratory steps.

MS Views and News
Providing educational information, resources and services for those affected by MS


Sunday, October 30, 2016

Dr.Boster teaches 10 Tips to tackle #MS pathologic fatigue


                                                                  
  




Click here to receive MS news via e-mail




MS Views and News
Providing educational information, resources and services for those affected by MS

CogFog in MS


                                                                  
  

Click here to receive MS news via e-mail


A silent description of Cognitive fogging in MS







MS Views and News
Providing educational information, resources and services for those affected by MS

Dr. Daniel Kantor and Dr. Edward Fox discussing the use of Biotin for progressing forms of MS.


                                                                  
  





Click here to receive MS news via e-mail



MS Views and News
Providing educational information, resources and services for those affected by MS